(2S)-1-[[(2R,3S)-5-CHLORO-3-(2-CHLOROPHENYL)-1-[(3,4-DIMETHOXYPHENYL)SULFONYL]-2,3-DIHYDRO-3-HYDROXY-1H-INDOL-2-YL]CARBONYL]-2-PYRROLIDINECARBOXAMIDE
CAS 150375-75-0 MFCD00922133
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Cytokines, Growth Factors and Hormones, Hormones, Pituitary Hormones, S, Sanofi Aventis, Vasopressin, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- Approved Therapeutics/Drug Candidates,
相关文献及参考
- Decaux G., et al., Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 9624th ed., 371 , 1624-1632, (2008)
- Bishara B., et al., Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure. J. Pharmacol. Exp. Ther. 2nd ed., 326 , 414-422, (2008) 摘要
- Serradeil-Le Gal, C., et al., Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors. J. Clin. Invest. 1st ed., 92 , 224-231, (1993) 摘要